cancer%20pain
CANCER PAIN
Cancer pain is an unpleasant sensory & emotional experience due to actual or potential tissue damage in patients with cancer.
Effective pain management in cancer patients with pain is an essential part of oncologic management due to increasing evidence of survival.
Pancreatic, head & neck cancer has a high prevalence of cancer pain.
During initial evaluation, follow-ups and new therapy initiation of patients with cancer, it is essential that they will be screened & evaluated for pain.
  1. Ministry of Health Malaysia, Malaysian Association for the Study of Pain, Academy of Medicine Malaysia. Clinical practice guidelines on management of cancer pain. MOH Malaysia. http://www.acadmed.org.my/index. Jul 2010.
  2. National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: adult cancer pain version 2.2015. NCCN. http://www.nccn.org/professionals/physician_gls/pdf/pain.pdf. 18 May 2015.
  3. Ripamonti CI, Santini D, Maranzano E, et al. Management of cancer pain: ESMO clinical practice guidelines. Annals of Oncology. 2012 Oct;23(Suppl 7):139-154. doi: 10.1093/annonc/mds233. PMID: 22997447
  4. World Health Organization. WHO’s cancer pain ladder for adults. WHO. http://www.who.int/cancer/palliative/painladder/en.
  5. National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: adult cancer pain. Version 2.2016. NCCN website. https://www.nccn.org/professionals/physician_gls/pdf/pain.pdf. Mar 2016. Accessed 29 Jul 2016.
  6. Bhatnagar S, Gupta M. Evidence-based Clinical Practice Guidelines for interventional pain management in cancer pain. Indian J Palliat Care. 2015 May;21(2):137-147. doi: 10.4103/0973-1075.156466. PMID: 26009665
  7. Ministry of Health Malaysia. Pain Management Handbook. Malaysia: Ministry of Health Malaysia; 2013. www.moh.gov.my/.
  8. Paice JA, Portenoy R, Lacchetti C, at al. Management of chronic pain in survivors of adult cancers: American Society of Clinical Oncology clinical practice guideline. J Clin Oncol. 2016 Jul. http://jco.ascopubs.org/content/early/2016/07/19/JCO.2016.68.5206.full.pdf. PMID: 27458286
  9. National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: Adult cancer pain version 2.2017. NCCN. https://www.nccn.org/. June 2017.
  10. Fallon M, Giusti R, Aielli F, et al; ESMO Guidelines Committee. Management of cancer pain in adult patients: ESMO Clinical Practice Guidelines. Ann Oncol. 2018 Jul. doi: 10.1093/annonc/mdy152. PMID: 30052758
  11. National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: adult cancer pain version 1.2018. NCCN. http://www.nccn.org/. 22 Jan 2018.
  12. National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: adult cancer pain version 3.2019. NCCN. http://www.nccn.org/. 24 Jun 2019.
  13. National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: Adult cancer pain. Version 1.2020. NCCN. https://www.nccn.org/. Apr 2020.
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Oncology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Christina Lau, 20 Apr 2020

Hippocampal avoidance during whole-brain radiotherapy (HA-WBRT), together with memantine, better preserves cognitive function vs WBRT plus memantine in patients with brain metastases, without compromising survival, a multi-institutional phase III trial has shown.

Natalia Reoutova, 20 May 2020

Cancer patients infected with coronavirus disease 2019 (COVID-19) appear to be at higher risk of severe outcomes, including death, but cancer type and treatment serve as better predictors, according to recent research presented at the American Association for Cancer Research (AACR) 2020 Virtual Annual Meeting I.

At the time of writing, COVID-19 has spread to more than 200 countries and territories, affecting an estimated 4.5 million people and killing over 300,000. Cancer, on the other hand, is newly diagnosed in 18 million people and takes the lives of 10 million every year.

“We have invited physician scientists who are at the epicentre of the COVID-19 pandemic, taking care of patients with cancer. They gathered prospective information to understand the effects of COVID-19 on patients with cancer, are testing new treatments, and are making this knowledge available to the global research community, so we can all benefit from their experience,” said Professor Antoni Ribas from UCLA Medical Center, Los Angeles, California, US, chairperson of the COVID-19 and cancer plenary session of the meeting.

4 days ago
Case presentation: The patient is a 46-year-old Korean lady who first presented with aggravating pleuritic chest pain characterised by a stabbing pain in the chest when inhaling and exhaling. A diagnosis of non-small cell lung cancer (NSCLC) was made from computed tomography (CT)-guided needle aspiration biopsy, and the tumour was found to be epidermal growth factor receptor (EGFR) mutation-positive (exon 19 deletion). Chest imaging revealed the presence of left-sided pleural seeding nodules. The patient was treated with afatanib with partial response as best response. Ten months after starting treatment, the patient experienced disease progression.